Mondias is aiming to become a leader in the development and commercialization of 100% natural solutions for unmet needs in the human health and agricultural markets.

With its vast experience in medical and pharmaceutical research and management’s many years of entrepreneurial success in the natural health product industry, Mondias is well-positioned for future growth.

corporate
presentation

Download
COMPANY NAME (-: -)
Last Trade (size) - (-) Open -
Change - - - Prev. Close -
Volume - Average Volume -
Day's Range - - - 52-wk Range - - -
Bid (size) - (-) Ask (size) - (-)
Last Trade Time -    

Mondias listed its common shares on the TSX Venture Exchange on November 28, 2018.

Shares outstanding: As of August 31, 2019

63,135,805

options: (avg. price of $0.22)

4,300,804

warrants: (avg. price of $0.25)

6,882,760

Shares fully diluted:

74,319,369

A total of 26,250,000 common shares issued to Mondias shareholders are escrowed pursuant to a TSX Venture Exchange Tier 2 value security escrow agreement.

Mondias Naturals - Investors

financial reports

Mondias’ financial reports
are available on SEDAR

sedar